# A Real-World Study of JT001 for COVID-19

> **NCT06142201** · — · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Vinnerna Biosciences Co., Ltd.** · enrollment: 7656 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** JT001

## Key facts

- **NCT ID:** NCT06142201
- **Lead sponsor:** Shanghai Vinnerna Biosciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-31
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 7656 (ACTUAL)
- **Last updated:** 2024-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06142201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06142201, "A Real-World Study of JT001 for COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06142201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*